Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Dec;170(6):361-75.
doi: 10.1007/s11046-010-9334-1. Epub 2010 Jun 25.

Acremonium species: a review of the etiological agents of emerging hyalohyphomycosis

Affiliations
Review

Acremonium species: a review of the etiological agents of emerging hyalohyphomycosis

Shukla Das et al. Mycopathologia. 2010 Dec.

Abstract

Unusual fungal agents that exist environmentally as saprophytes can often lead to opportunistic infections. Hyalohyphomycosis is a group of fungal infections caused by fungi characterized by hyaline septate hyphae and can infect both immunocompetent as well as immunocompromised patients. Many a times it becomes difficult to distinguish a pathogenic and a contaminant fungus, because many such agents can assume clinical significance depending on circumstances. Subcutaneous and invasive fungal infection due to the emerging hyalohyphomycotic fungus, Acremonium, has drawn the attention of clinicians and microbiologists, as a potential pathogen in patients with and without underlying risk factors. Generally considered to be minimally invasive in the past, genus Acremonium has been responsible for eumycotic mycetomas and focal infections in otherwise healthy individuals. It has also been increasingly implicated in systemic fungal diseases. The management with different antifungals in various clinical situations has been very conflicting and hence needs to be carefully evaluated. This overview is an endeavor to consolidate the available clinical infections due to Acremonium and the recommendations on treatment.

PubMed Disclaimer

References

    1. Ann Dermatol Venereol. 2003 Dec;130(12 Pt 2):1237-43 - PubMed
    1. Orv Hetil. 1987 Nov 29;128(48):2529-32 - PubMed
    1. Clin Infect Dis. 1995 Jan;20(1):197-8 - PubMed
    1. J Med Microbiol. 2003 Sep;52(Pt 9):835-837 - PubMed
    1. Sabouraudia. 1966 Oct;5(2):99-103 - PubMed

MeSH terms

Substances

LinkOut - more resources